At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.
A Government Accountability Office report warns that the FDA has no framework for augmentation uses of brain-computer interfaces, even as military and commercial applications advance.
Synchron ranked eighth on Fast Company's 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.
Tohoku University researchers trained cultured rat cortical neurons to produce sine waves, square waves, and chaotic Lorenz attractors using closed-loop FORCE learning, demonstrating that biological neural networks can serve as computational resources.
Cleveland-based Neuronoff showed its Injectrode platform can connect to off-the-shelf implantable pulse generators, opening neuromodulation targets beyond the spine.
Brain-computer interfaces appeared in China's government work report for the first time during the 2026 'two sessions,' placing the technology alongside quantum computing and 6G as a national strategic priority.
University of Iowa researchers have demonstrated for the first time that non-invasive transcranial magnetic stimulation can modulate hippocampal activity when the stimulation site is tailored to each patient's brain connectivity.
Galen Buckwalter, a quadriplegic research psychologist with six Utah arrays in his brain, is using a Caltech-developed interface to generate music directly from neural signals.
Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.